GPR114/ADGRG5 is activated by its tethered-peptide-agonist because it is a cleaved adhesion GPCR.

Family B2 or Adhesion GPCRs (AGPCRs) are distinguished by variable extracellular regions that contain a modular protease, termed the GPCR autoproteolytic domain (GAIN) that self-cleaves the receptor into an N-terminal fragment (NTF) and a C-terminal fragment (CTF), or seven transmembrane domain (7TM). The NTF and CTF remain bound after cleavage through noncovalent interactions. NTF binding to a ligand(s) presented by nearby cells, or the extracellular matrix anchors the NTF, such that cell movement generates force to induce NTF/CTF dissociation and expose the AGPCR tethered peptide agonist (TA). The released TA binds rapidly to the 7TM orthosteric site to activate signaling. The orphan AGPCR, GPR114 was reported to be uncleaved, yet paradoxically capable of activation by its TA. GPR114 has an identical cleavage site and TA to efficiently cleaved GPR56. Here we used immunoblotting and biochemical assays to demonstrate that GPR114 is a cleaved receptor, and the self-cleavage is required for GPR114 TA-activation of G protein s and no other classes of G proteins. Mutagenesis studies defined features of the GPR114 and GPR56 GAIN subdomains that influenced self-cleavage efficiency. Thrombin treatment of protease activated receptor (PAR) 1 leader / AGPCR fusion proteins demonstrated that acute decryption of the GPR114/56 TAs activated signaling. GPR114 was found to be expressed in an eosinophilic-like cancer cell line (EoL-1 cells) and endogenous GPR114 was efficiently self-cleaved. Application of GPR114 TA peptidomimetics to EoL-1 cells stimulated cAMP production. Our findings may aid future delineation of GPR114 function in eosinophil cAMP signaling related to migration, chemotaxis or degranulation.